Skip to Content
Merck
  • Multivalent cationic pseudopeptide polyplexes as a tool for cancer therapy.

Multivalent cationic pseudopeptide polyplexes as a tool for cancer therapy.

Oncotarget (2017-11-23)
Zoi Diamantopoulou, Maud-Emmanuelle Gilles, Maha Sader, Mélissande Cossutta, Benoit Vallée, Claire Houppe, Damien Habert, Blandine Brissault, Eric Leroy, Federica Maione, Enrico Giraudo, Damien Destouches, Jacques Penelle, José Courty, Ilaria Cascone
PMID29163814
ABSTRACT

In this study, a novel anticancer reagent based on polyplexes nanoparticles was developed. These nanoparticles are obtained by mixing negatively charged polyelectrolytes with the antitumour cationically-charged pseudopeptide N6L. Using two